Table 3.
Antibiotic susceptibility profiles of the 17 strains.
| Antibiotic category | Name of antibiotic | LA1 | LA2 | LA3 | LA4 | LA6 | LS1 | LS3 | LS4 | LS5 | LS9 | LR1 | LR5 | LR6 | LJ1 | EB1 | cLA | cLP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Macrolide | Erythromycin | S | S | S | S | S | R | R | R | R | R | S | S | S | S | S | I | S |
| Clarithromycin | S | S | S | S | S | R | R | I | I | R | S | S | S | S | S | R | S | |
| Lincomycin | Clindamycin | S | S | S | S | S | R | R | R | R | R | S | S | S | S | S | S | S |
| Chloramphenicol | Chloramphenicol | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| Nitrofuran | Nitrofurantoin | S | S | S | S | S | I | I | I | I | S | S | S | S | S | S | I | S |
| Beta-lactam | Penicillin | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | R | R |
| Oxacillin | R | I | R | R | R | R | R | R | R | R | R | I | I | R | R | I | R | |
| Tetracycline | Tetracycline | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | I | I |
| Minocycline | R | S | R | I | R | R | I | I | I | I | R | I | I | R | I | I | R | |
| Quinolone a | Norfloxacin | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| Ciprofloxacin | R | R | R | R | R | I | R | I | I | I | R | R | R | R | R | R | R | |
| Ofloxacin | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |
| Polypeptide | Vancomycin | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| Polymyxin B | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |
| Sulfonamides | Sulfamethoxazole | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | S |
| Aminoglycoside | Spectinomycin | R | R | R | R | R | I | R | R | R | R | R | R | R | R | R | I | R |
“S” indicates sensitive, “R” indicates insensitive, and “I” indicates intermediate between sensitive and insensitive.